The following is a summary of “Clinical Outcomes of Switching U-100 Intermediate or Basal Insulin to U-200 Insulin Degludec or U-300 Insulin Glargine,” published in the March 2025 issue of […]
The post Switch from U-100 to U-200 or U-300 Insulin Improves Clinical Outcomes first appeared on Blackandmed .
